Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel Diseases

Published:2020-01 Issue:1 Volume:18 Page:257-258
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Fenster Marc,Ungaro Ryan C.,Hirten Robert,Gallinger Zane^ORCID,Cohen Louis,Atreja Ashish,Mehandru Saurabh,Colombel Jean-Frederic,Cohen Benjamin L.

Funder

NIH

Crohn’s and Colitis Foundation Career Development

NIDDK

Canadian Association of Gastroenterology

Kenneth Rainin Foundation Synergy

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference8 articles.

1. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

2. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

3. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

4. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;N Engl J Med,2013

5. Assuring quality for non-hospital-based biologic infusions in pediatric inflammatory bowel disease: a clinical report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition;Barfield;J Pediatr Gastroenterol Nutr,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home- vs Office-Based Biologic Infusions;Inflammatory Bowel Diseases;2023-10-11

2. Home versus outpatient hospital intravenous immunoglobulin infusion and health care resource utilization;Journal of the American Pharmacists Association;2023-09

3. Outcomes for Standardized Home and Hospital-Based Infusions of Infliximab for Children With Inflammatory Bowel Disease;Journal of Pediatric Gastroenterology & Nutrition;2023-03-16

4. Inflammatory bowel disease patient concerns and experiences on transition to home-based infusions during the COVID-19 pandemic;Research in Social and Administrative Pharmacy;2022-12

5. Denials, Dilly-dallying, and Despair: Navigating the Insurance Labyrinth to Obtain Medically Necessary Medications for Pediatric Inflammatory Bowel Disease Patients;Journal of Pediatric Gastroenterology & Nutrition;2022-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3